Assessing the impact of changes in the management of Ulcerative Colitis patients who have an incomplete response to TNFa Therapy
Lack of treatment options resulted in UC patients left on TNFa with dose intensification, adjunct steroids or other therapy combinations despite failing to achieve remission.
How has the approval of novel therapies changed practice and patient outcomes?
Using a representative study population with detailed clinical data from gastroenterology practices, assessed treatment patterns and patient and clinical characteristics associated with switching.
*Counts based on Q3 2022 release
UC patients with deep clinical data and clinical notes
UC patients treated with advanced therapies